Seminur Haznedaroglu

Prof. Dr. Seminur Haznedaroglu


Research Focus & Metrics

Representative Publications

View All Publications
7 August 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
NANuh Atas
Nuh Atas
BABerkan Armağan
Berkan Armağan
EBErdal Bodakçi
Erdal Bodakçi
HSHasan Satis
Hasan Satis
ASAlper Sari
Alper Sari
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN

24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SYSongul Baglan Yentur
Songul Baglan Yentur
SKSaliha Karatay
Saliha Karatay
DODeran Oskay
Deran Oskay
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN
HKHamit Küçük
Hamit Küçük
SHSeminur Haznedaroglu
Seminur Haznedaroglu
This study was designed to investigate the relationship between kinesiophobia and the level of physical activity, depression, disease activity, fatigue, pain, and quality of life in female patients with systemic lupus erythematosus (SLE). Seventy volunteer female patients were included in the study. Kinesiophobia, physical activity level, disease activity, fatigue, depression, pain, and quality of life were assessed using the Tampa Scale for Kinesiophobia (TSK), International Physical Activity Questionnaire- Short Form (IPAQ), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF) and Nottingham Health Profile (NHP), respectively. Two-thirds of the patients in the study had a high degree of kinesiophobia. Although there was a significant correlation between kinesiophobia and depression and some subscales of quality of life (sleep, social isolation, emotional reactions) (P < 0.05), no significant correlation with other parameters was found. As a result of this study, the majority of SLE patients included in the study were identified as having high levels of kinesiophobia. Patients’ fear and avoidance reaction from movement can be influenced by psychosocial factors. Treatments focusing on kinesiophobia of SLE patients could be beneficial in increasing the success of rehabilitation.

5 May 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HSHasan Satiş
Hasan Satiş
BABerkan Armağan
Berkan Armağan
EBErdal Bodakçi
Erdal Bodakçi
NANuh Ataş
Nuh Ataş
ASAlper Sari
Alper Sari
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN
Colchicine is the mainstay of treatment in FMF. However, in daily practice, it is not easy to maintain effective colchicine doses in substantial number of patients, due to its side effects. In this study, we aimed to investigate prevalence and risk factors for colchicine side effects that limit optimal drug dosing and permanent discontinuation. All patients were recruited from "FMF in Central Anatolia? (FiCA) cohort, 915 adult subjects with minimum follow up time of 6 months and had compliance of treatment were included. Demographic and anthropometric data, FMF disease characteristics, disease severity, complications and treatment features were recorded on a web based registry. Prevalence of colchicine intolerance and characteristics of intolerant patients were analyzed. Effective colchicine doses cannot be maintained in 172 (18.7%) subjects. Main side effects that limit optimal dosing were as follows; diarrhea in 99 (10.8%), elevation in transaminases in 54 (5.9%), leukopenia in 10 (%1.1), renal impairment in 14 (1.3%), myopathy in 5 (0.5%) and allergic skin reaction in two. Colchicine had to be permanently ceased in 18 (2%) patients because of serious toxicity. Male gender and obesity were found to be associated with liver toxicity and having normal body weight was associated with diarrhea. Chronic inflammation and proteinuria were more common in colchicine intolerant patients and they had reported more frequent attacks compared to those tolerating optimal doses. Conclusion Colchicine intolerance is an important problem in daily clinical practice, mainly due to diarrhea and liver toxicity. Suboptimal colchicine dosing associated with complications.

23 July 2020 in European Journal of Rheumatology
Verified
Journal Article
Open access
NANuh Ataş
Nuh Ataş
HBHakan Babaoglu
Hakan Babaoglu
EDErtuğrul Demirel
Ertuğrul Demirel
BÇBülent Çelik
Bülent Çelik
RBReyhan Bilici
Reyhan Bilici
MÖMehmet Akif Öztürk
Mehmet Akif Öztürk
Objective: Behçet’s disease (BD) is a chronic, multisystem disorder that can cause severe morbidity and mortality. Monitoring tools that measure disease activity are required for effective management of BD. We aimed to investigate the association of prognostic nutritional index (PNI) with disease activity in BD. Methods: In this cross-sectional study, we enrolled 88 adult patients with BD and 51 healthy controls. The patients were divided into patients with active and inactive BD according to their disease activities. PNI was calculated using the following formula: 10×serum albumin (g/dL)+0.005×peripheral lymphocyte count (per mm3). To evaluate BD activity, the Behçet Disease Current Activity Form was used. The relations of BD activity with PNI, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, erythrocyte sedimentation rate, and C-reactive protein were investigated. A receiver operator characteristic curve analysis was used to define the optimum cutoff value of PNI for active BD. Results: A total of 48 patients were classified as having active BD and 40 as having inactive BD. Patients with active BD had lower mean PNI than patients with inactive BD and healthy controls (51.8±4.2, 57.4±2.9, and 56.6±3.6, respectively; p<0.001). In multivariate analysis, PNI was the only independent predictor of BD activity (odds ratio, -0.687; 95% confidence interval 0.548-0.861; p=0.001). The optimum cutoff of PNI for active BD was 55.35 with 79.2% sensitivity and 77.75% specificity. Conclusion: PNI was significantly associated with BD activity. PNI may be a useful tool for the assessment of disease activity in BD. Cite this article as: Ataş N, Babaoğlu H, Demirel E, Çelik B, Bilici Salman R, Satış H, et al. Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease. Eur J Rheumatol 2020; 7(3): 99-104.

1 July 2019 in Joint Bone Spine
Verified
Journal Article
Closed access
SESakine Güzel Esen
Sakine Güzel Esen
BABerkan Armağan
Berkan Armağan
NANuh Atas
Nuh Atas
MUMurat Ucar
Murat Ucar
ÖVÖzkan Varan
Özkan Varan
ATABDURRAHMAN TUFAN
ABDURRAHMAN TUFAN

1 January 2015 in Journal of Physical Therapy Science
Verified
Journal Article
Open access
ZTZeynep Tuna
Zeynep Tuna
TDTulin Duger
Tulin Duger
NANevin Atalay-Guzel
Nevin Atalay-Guzel
AAArzu Aral
Arzu Aral
BBBilkay Basturk
Bilkay Basturk
BGBerna Goker
Berna Goker
[Purpose] Although oxidative stress is known to be present in rheumatoid arthritis (RA), the effects of exercise on oxidative parameters are unknown. The aim of this study was to investigate the effects of acute aerobic exercise on serum oxidant and antioxidant levels in patients with RA. [Subjects and Methods] Sixteen patients with RA and 10 age-matched healthy volunteers participated in this study. All participants wore polar telemeters and walked on a treadmill for 30 minutes at a speed eliciting 60-75% of maximal heart rates. Blood samples were obtained before, immediately and 24 hours after exercise and malondialdehyde (MDA) and total sulfhydrile group (RSH) levels were measured. [Results] Both groups had similar heart rates during the test but the treadmill speed of the RA patients was significantly lower than that of the healthy volunteers. Serum MDA levels were lower than in both groups immediately after exercise, with greater decrements in the RA patients than controls. MDA levels returned to baseline 24 hours after the exercise only in the controls; they remained low in the RA patients. There was a slight increase in serum RSH levels after exercise compared to baseline in both groups. [Conclusion] Moderate intensity treadmill exercise did not have any adverse effect on the oxidant-antioxidant balance. The results suggest that such an exercise may be safely added to the rehabilitation program of RA for additional antioxidant effects. Morever, this antioxidant environment is maintained longer in RA patients.